VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
Politico: House Majority Leader Steny Hoyer "said Tuesday that the abortion fight 'has to be resolved.' The majority leader expressed confidence that the issue would be wrapped up, but he also cautioned reporters that he had not had any formal negotiations with Rep. Bart Stupak, the Michigan Democrat who authored the House abortion restrictions. ...
bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.
House Majority Leader Steny Hoyer (D-Md.) on Tuesday pledged to work with Rep. Bart Stupak (D-Mich.) to resolve the dispute over abortion-coverage language in the Senate health reform bill (HR 3590), CQ Today reports. Hoyer said the issue "has to be resolved," adding, "I think it will be resolved one way or the other, and the bill will be passed...
A recent decision by the U.S. Department of Agriculture (USDA) to scrap a national animal identification system could seriously hinder U.S. veterinarians' ability to track diseased animals and prevent the spread of those diseases -diseases that could spread to humans and cost U.S. farmers millions of dollars. That's the message that Dr...
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
Senator Frank R. Lautenberg (D-NJ), a longtime Senate leader in the fight against the tobacco industry, applauded the Food and Drug Administration's decision to continue their efforts to regulate electronic cigarettes...
As the MetroPCS Dallas White Rock Marathon turns a fabulous forty, NexBank, a North Texas leader in banking and financial services, returns as presenting sponsor for the third consecutive year with goals to further extend the race’s annual philanthropic impact benefiting Texas Scottish Rite Hospital for Children.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced results from a pilot clinical study which demonstrated the substantially enhanced weight loss effects of combining the company's EndoBarrier Gastrointestinal Liner with a new EndoBarrier Flow Restrictor.
In order to recognize and encourage cutting-edge research in key areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine (AOSSM) will present eight research awards and two grants during its Annual Meeting, July 9-12th in Keystone, Colorado. As a leader in orthopaedic sports medicine, AOSSM annually provides more than $150,000 to research initiatives and projects around the country.
Sports & Orthopaedic Specialists, a national leader in orthopedic care for women, in collaboration with Sister Kenny Sports and Physical Therapy, launched the renowned Prevent Injury and Enhance Performance (PEP) program to the local and regional market. PEP is an exercise and training program designed to significantly reduce the incidence of ACL injury and enhance performance as an added benefit. Aimee S. Klapach, M.D.
Appearing on CBS' "Face the Nation" on Sunday, Senate Minority Leader Mitch McConnel (R-Ky.) said that Senate Republicans have not ruled out a filibuster on the Supreme Court nomination of Judge Sonia Sotomayor, The Hill reports.
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, announced today that the company has increased the availability of two veterinary medicines, Huangqiduotang vaccine and Jinfang Detoxification Powder to treat swine flu that has recently spread in North America and other parts of the world.
VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, announced that the UK NHS National Innovation Centre has identified the VNUS Closure(R) procedure as a select innovative technology that is bringing benefits to National Health Service (NHS) hospitals and patients.
